etoposide has been researched along with thiourea in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gergely, P; Hrabák, A; Mihalik, R; Nagy, E; Vértesi, C | 1 |
| Ahola, T; An, X; Bai, M; Han, W; Hanski, L; Li, X; Mei, Q; Wu, Z | 1 |
| Nazha, B; Owonikoko, TK | 1 |
3 other study(ies) available for etoposide and thiourea
| Article | Year |
|---|---|
Apoptosis inhibitory effect of the isothiourea compound, tri-(2-thioureido-S-ethyl)-amine.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Caspase Inhibitors; Cerebellum; DNA Fragmentation; Etoposide; fas Receptor; Flow Cytometry; HL-60 Cells; Humans; Intracellular Membranes; Jurkat Cells; Membrane Potentials; Mitochondria; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Thiourea; U937 Cells | 2000 |
Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy.
Topics: Animals; Antineoplastic Agents; Carboxylic Ester Hydrolases; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; DNA; Drug Synergism; eIF-2 Kinase; Enzyme Inhibitors; Etoposide; Heterografts; Humans; I-kappa B Kinase; Isothiocyanates; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; NF-kappa B; Protein Binding; Signal Transduction; Thiourea; Treatment Outcome | 2017 |
The clinical conundrum of managing relapsed small cell lung cancer.
Topics: Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Carboplatin; Clinical Decision-Making; Disease Progression; Etoposide; Humans; Immunoconjugates; Irinotecan; Liver Neoplasms; Lung Neoplasms; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Nivolumab; Paclitaxel; Piperazines; Pyrimidines; Salvage Therapy; Small Cell Lung Carcinoma; Temozolomide; Thiourea; Topotecan | 2019 |